SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001615774-17-001325
Filing Date
2017-03-30
Accepted
2017-03-29 21:55:33
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 s105714_424b5.htm 424B5 653114
2 GRAPHIC pg01img01_424b5.jpg GRAPHIC 8994
3 GRAPHIC pg48img01_424b5.jpg GRAPHIC 12189
4 GRAPHIC pg85img01_424b5.jpg GRAPHIC 13441
  Complete submission text file 0001615774-17-001325.txt   702305
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-197824 | Film No.: 17723616
SIC: 2834 Pharmaceutical Preparations